CD274 and neoplasm: Sequential intravenous injections of STAT3 siRNA resulted in profound suppression of STAT3 expression in tumor tissue, resulting in considerable downregulation of programmed death ligand‐1 (PD-L1) and significant tumor growth inhibition via inactivation of the tumor immune checkpoint.